Clin2
NCT07378072Possibly a fitRecruiting

12-week daytime eating study for fatty liver in obesity

MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)

Part of Hormones & metabolism clinical trials.

This study tests if restricting eating to daytime hours for 12 weeks can reduce liver fat in people with obesity. It aims to help those with fatty liver disease improve their health without medication.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
72 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • Body mass index (BMI) between 30 and 49.9
  • Age 18 to 65 years old
  • Not very active (light exercise less than 1 hour per week) or moderately active (1 to 2 hours per week)
  • Weight stable for at least 3 months (no gain or loss over 4 kg)
  • Usually eat over more than 12 hours each day
  • Own a smartphone with internet and agree to use it for the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06705868Not yet recruiting
Meal timing study for fatty liver disease

This study tests whether changing when you eat (for example, shortening your daily eating window) can help improve liver health in people with fatty liver disease. If you qualify, you would receive guidance on meal timing and may help researchers learn if this approach reduces liver fat and improves overall health.

Limassol
NCT04873258Recruiting
Test a non-invasive tool to screen for fat-related liver disease

This study looks at a new non-invasive screening method to predict metabolic dysfunction–associated steatotic liver disease (MASLD), a condition where fat builds up in the liver. The goal is to help identify people who may be at risk without needing invasive tests.

London, London
NCT07193927Recruiting· Phase 2
Testing a probiotic mix for fatty liver disease (MASLD)

This trial tests whether a probiotic mixture can improve liver health in people with moderate fatty liver disease (MASLD). It looks at how the probiotic affects liver fat, inflammation, and metabolism.

Girona, Girona
NCT07313007Recruiting
Gut bacteria chemicals in fatty liver disease

This study looks at whether the natural chemicals made by your gut bacteria from the food you eat could affect liver fat and health. If you have MASLD (a fatty liver condition), researchers want to measure these gut-produced substances to better understand the disease.

Pierre-Bénite
NCT07652151Recruiting
Fatty Liver Disease Study Using Wearable Tracking

This research studies fatty liver disease linked to metabolic problems like diabetes and obesity. You'll wear a fitness tracker and have liver imaging to help doctors understand the disease and find new treatments.

Roma
NCT07097506Recruiting· Phase 2
Ketone drink for liver fat and health

This study tests whether a daily ketone ester drink can reduce liver fat and improve metabolism in people with excess liver fat. You may join if you are 18–40, have overweight or obesity, and your liver has extra fat.

St Louis, Missouri

Hear when a new MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.